NCT01928537 2020-06-30Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or DecitabineTraws Pharma, Inc.Phase 3 Completed67 enrolled
NCT00854945 2017-06-26Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AMLTraws Pharma, Inc.Phase 1/2 Completed36 enrolled